UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics Health"), This time last year, Wellgistics was a private company, weathering the ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

BioTechnique is an American pharmaceutical contract research, development and manufacturing facility filling the need for therapeutic and highly potent sterile injectable products - both liquid and ...

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...

MOOVair wireless charging technology powers smart fleets with high efficiency, zero contact, and no manual intervention.

In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for ...

Medical device makers, hospitals and other key health industries are pressing to gain exemptions under the Trump ...

Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

All of Britain’s fiscal headroom could be wiped out immediately if US president Donald Trump presses ahead with his hikes in ...

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...